Showing results (31-40 of 40) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 40 results.
Blood Purification|January 1, 1996
Blood purification procedures for acute renal failure: convenient strategy related to clinical conditionsC Meloni, M Morosetti, L Meschini, et al.
Blood Purification|July 29, 1998
Cardiac function and oxygen balance in septic patients during continuous hemofiltrationC Meloni, M Morosetti, F Turani, et al.
ASAIO Transactions|July 1, 1988
Extracorporeal blood recirculation and beta-2-microglobulin plasma levels during hemodialysisS Di Giulio, G Splendiani, A Sturniolo, et al.
Histology and Histopathology|December 15, 2010
Medial artery calcification of uremic patients: a histological, histochemical and ultrastructural studyP Ballanti, G Silvestrini, S Pisanò, et al.
Lancet (London, England)|October 11, 1980
Carnitine improves lipid anomalies in haemodialysis patientsB Lacour, S Di Giulio, J Chanard, et al.
American Journal of Nephrology|August 30, 2008
Bone turnover, osteopenia and vascular calcifications in hemodialysis patients. A histomorphometric and multislice CT studyG Coen, P Ballanti, D Mantella, et al.
Giornale Italiano Di Nefrologia : Organo Ufficiale Della Societa Italiana Di Nefrologia|March 8, 2006
[Update of the Italian Society of Nephrology Project No. 1 of the 2004-2006 SIN programme]C Manno, M Virgilio, A Giangrande, et al.
Giornale Italiano Di Nefrologia : Organo Ufficiale Della Societa Italiana Di Nefrologia|December 14, 2004
[Italian Registry of Dialysis and Transplantation: 1996-2001 experience]F Conte, G Cappelli, F Casino, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|February 13, 2002
Risk management of HBsAg or anti-HCV positive healthcare workers in hospitalA Mele, G Ippolito, A Craxì, et al.
Giornale Italiano Di Nefrologia : Organo Ufficiale Della Societa Italiana Di Nefrologia|July 9, 2013
[Effects of dose of erythropoiesis stimulating agents on cardiovascular outcomes, quality of life and costs of haemodialysis. the clinical evaluation of the DOSe of erythropoietins (C.E. DOSE) Trial]V Saglimbene, D D'Alonzo, M Ruospo, et al.
Pageof 4